In breast cancers, Gal3 expression may be associated with specific morphological precursor subtypes and undergoes a transitional shift in expression from luminal to peripheral cells as tumors progress to comedo-type ductal carcinoma in situ or invasive carcinomas [12, 13]. Here, LGALS3 is linked to breast carcinoma.